Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Imipramine and PDT for Actinic Keratosis
NCT06778434Phase 2Recruiting
- Sponsor
- VA Office of Research & Development
- Start
- Apr 2025
- Primary completion
- Mar 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of imipramine in actinic keratosis (AK), sponsored by VA Office of Research & Development. Started Apr 2025; status: recruiting.
02
Drugs
imipramine
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT06778434.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06778434.